We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Projects granted during 2014 that have a primary purpose of basic research: multisystemic.
Projects granted during 2014 that have a primary purpose of basic research: oncology.
Projects granted during 2015 that have a primary purpose of basic research: cardiovascular, blood and lymphatic system.
Dr Graham Shortland qualified from the University of Southampton in 1983. He trained in NHS and academic posts in Southampton, Cardiff and Bristol. He has published research in the areas of paediatric nutrition, inherited metabolic disease, medical education and clinical...
With the exception of medicines containing zidovudine, stavudine, or didanosine, product information will no longer include warnings on fat redistribution or lactic acidosis.
Inform specialist or designated phenylketonuria (PKU) teams that a baby's newborn blood spot screen has found raised levels of phenylalanine and tyrosine.
Letter templates to inform hospitals, or accident and emergency departments, about a baby screened positive for an inherited metabolic disease.
Reminder to monitor and manage weight, glucose, and lipid levels.
MHRA and the Bill & Melinda Gates Foundation have begun new research on medicine use which could impact the health of pregnant women around the world.
Public Health England highlights the success of the NHS Newborn Blood Spot Screening Programme in diagnosing babies with rare diseases.
The London 2012 anti-doping facilities will be developed after the Olympic and Paralympic Games into a world-class resource that could help revolutionise healthcare.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.